| Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs | Frank Vinluan | 09/02/20 | Seattle |
| Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs | Frank Vinluan | 05/04/20 | Boston |
| Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic | Sarah de Crescenzo | 03/25/20 | New York |
| Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More | Ben Fidler | 06/14/19 | National |
| NY’s Research Institutions Must Keep Working Together in ‘19 | Orin Herskowitz | 12/31/18 | New York |
| Cannon Ventures, Pensa Systems, FloSports, Kopser Wins & More TX Tech | Angela Shah | 06/01/18 | Texas |
| Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech | Ben Fidler | 03/08/18 | New York |
| Will Fast-Growing Kallyope Stay in New York After New $66M Round? | Ben Fidler | 02/22/18 | New York |
| Columbia Spinout Allure Security Bags $5.3M to Guard Business Data | Jeff Bauter Engel | 01/25/18 | Boston |
| Have $100M, Looking For Ideas: NYCEDC Begins Search For a NY Bio Campus | Ben Fidler | 01/24/18 | New York |
| After Equifax: Should Tech Entrepreneurs Design the Next-Gen Credit Agency? | Bernadette Tansey | 09/15/17 | San Francisco |
| For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY | Ben Fidler | 08/09/17 | New York |
| Last Chance to Save on “New York Biotech Seizes the Momentum” | Jamie Gulden | 05/25/17 | New York |
| Hurry & Save 20 Percent on New York Biotech Seizes the Momentum | Jamie Gulden | 05/17/17 | New York |
| Talk NY Bio With Schadt, Varmus & More on May 31: Discount Ends Today | Jamie Gulden | 04/11/17 | New York |
| Join Varmus, Foley & More at NY Biotech Seizes the Momentum on May 31 | Ben Fidler | 03/21/17 | New York |
| With $19M, Axial Becomes Latest Startup to Target Gut-Brain Connection | Ben Fidler | 11/30/16 | Boston |
| Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK | Alex Lash | 06/15/16 | New York |
| “Be Vulnerable, With Confidence,” Keeton Advises Women Entrepreneurs | Angela Shah | 05/13/16 | Texas |
| East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More | Ben Fidler | 05/12/16 | Boston |
| Amid Leadership Changes, NY Biotech Braces For its “Pivotal Moment” | Ben Fidler | 05/12/16 | New York |
| PureTech’s Alivio Debuts With Drug-Delivery Gel for Inflammation | David Holley | 05/10/16 | Boston |
| “Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors | Ben Fidler | 03/30/16 | New York |
| Hear Lew Cantley, Others on Shaping NY Biotech on March 29 | Ben Fidler | 03/11/16 | New York |
| New York’s Life Science Disruptors on March 29: Here’s the Agenda | Ben Fidler | 03/03/16 | New York |
| New York City: En Route to a Bio Cluster | Louis Levy and Vicki Sato | 02/29/16 | New York |
| NYCEDC Bets on Streamlined Pilot Studies to Buoy NY Healthtech Startups | Ben Fidler | 02/25/16 | New York |
| Roundup: URC Report, Harman, Global Detroit, TechShop & More | Sarah Schmid Stevenson | 01/26/16 | Detroit Ann Arbor |
| NYC’s Disruptive Biotech Startups take the Stage on March 29 | Ben Fidler | 01/21/16 | New York |
| Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup | Ben Fidler | 01/10/16 | New York |
